Search - tctmd.com

Displaying 201 - 220 of 221

Sort: Relevancy | Date

News Daily News

PACIFIER Published: Drug-Eluting Balloon Helps Treat Femoropopliteal Lesions

Caitlin E. Cox

December 09, 2012

Presentation

Paclitaxel-Coated Balloons Reduce Restenosis After Femoropopliteal Angioplasty

Presenter: Michael Werk

December 06, 2012

Presentation TCT 2012

DEBATE-BTK: A Prospective, Randomized Trial of Paclitaxel Coated Balloon Angioplasty in Diabetic Patients with Critical Limb Ischemia Undergoing Angioplasty of Below-the-Knee...

Presenter: Francesco Liistro

October 25, 2012

Presentation TCT 2012

TCT-69. PEPCAD-DES: A Randomized, Multicenter, Single Blinded Trial Comparing Paclitaxel Coated Balloon Angioplasty with Plain Balloon Angioplasty in Drug-eluting-stent...

Presenter: Harald Rittger

October 23, 2012

Presentation TCT 2012

DEBATE-SFA: A Prospective, Randomized Trial of Paclitaxel Coated Balloon Angioplasty Prior to Nitinol Stenting in Patients with SFA and Popliteal Lesions

Presenter: Francesco Liistro

October 22, 2012

News Daily News

Drug-eluting Balloons Show Positive Results in Treating In-stent Restenosis

Jason Kahn

October 05, 2012

News Daily News

Meta-analysis: Paclitaxel-Coated Balloon Reduces TLR in Femoropopliteal Disease

August 07, 2012

Presentation

Paclitaxel-Coated vs. Uncoated Balloon Angioplasty Reduces TLR in Femoropopliteal Disease

Presenter: S. Cassese

August 06, 2012

News Industry News

Cardionovum® begins in vivo testing of its paclitaxel-coated RESTORE® drug-eluting balloon (DEB), designed to increase drug-in-tissue concentration

July 03, 2012

News Industry News

Medtronic IN.PACT Drug-Eluting Balloon Studies Show Significant Benefit of Novel Medical Device in Treating Narrowed Arteries

May 16, 2012

News Daily News

PEPCAD-DES: Paclitaxel-Coated Balloon Bests Plain Balloon for DES Restenosis

March 05, 2012

Presentation

A Prospective Multicenter Trial Comparing Paclitaxel-Coated Balloon Angioplasty with Uncoated Balloon Angioplasty in DES Restenosis

Presenter: Harald Rittger

February 28, 2012

Presentation TCT 2012

The Pacifier Trial. A Randomized Multicenter Trial Evaluating Prevention of Restenosis with Paclitaxel-Coated PTA Balloon Catheters in Stenosis or Occlusion of Femoropopliteal...

Presenter: Michael Werk, Thomas Albrecht, Dirk R. Meyer, Heiner Stiepani, Beatrix Schnorr, Enrique Lopez H?nninen

January 03, 2012

Presentation TCT 2012

5-year THUNDER Follow-Up: Patients with PAD Treated with Uncoated Versus Paccocath Paclitaxel Coated Balloons.

Presenter: Gunnar Tepe

January 03, 2012

News Conference News

PEPCAD-DES: Drug-Coated Balloon Better Than Uncoated Balloon for DES Restenosis

November 27, 2011

News Conference News

Drug-Eluting Balloons an Option for Patients with BMS Restenosis, High Bleeding Risk

November 17, 2011

News Industry News

Paclitaxel-coated balloon angioplasty demonstrates superior results

November 10, 2011

News Daily News

Drug-Eluting Balloon Continues to Show Positive Results in SFA, Popliteal Disease

Jason Kahn

September 15, 2011

News Conference News

EuroPCR 2011: Novel Technologies with Transformative Potential Stand Out

May 23, 2011

News Conference News

Paclitaxel Balloon Maintains Advantage at 5 Years

Caitlin E. Cox

May 20, 2011

Advertisement

PACIFIER Published: Drug-Eluting Balloon Helps Treat Femoropopliteal Lesions

Paclitaxel-Coated Balloons Reduce Restenosis After Femoropopliteal Angioplasty

DEBATE-BTK: A Prospective, Randomized Trial of Paclitaxel Coated Balloon Angioplasty in Diabetic Patients with Critical Limb Ischemia Undergoing Angioplasty of Below-the-Knee...

TCT-69. PEPCAD-DES: A Randomized, Multicenter, Single Blinded Trial Comparing Paclitaxel Coated Balloon Angioplasty with Plain Balloon Angioplasty in Drug-eluting-stent...

DEBATE-SFA: A Prospective, Randomized Trial of Paclitaxel Coated Balloon Angioplasty Prior to Nitinol Stenting in Patients with SFA and Popliteal Lesions

Drug-eluting Balloons Show Positive Results in Treating In-stent Restenosis

Meta-analysis: Paclitaxel-Coated Balloon Reduces TLR in Femoropopliteal Disease

Paclitaxel-Coated vs. Uncoated Balloon Angioplasty Reduces TLR in Femoropopliteal Disease

Cardionovum® begins in vivo testing of its paclitaxel-coated RESTORE® drug-eluting balloon (DEB), designed to increase drug-in-tissue concentration

Medtronic IN.PACT Drug-Eluting Balloon Studies Show Significant Benefit of Novel Medical Device in Treating Narrowed Arteries

PEPCAD-DES: Paclitaxel-Coated Balloon Bests Plain Balloon for DES Restenosis

A Prospective Multicenter Trial Comparing Paclitaxel-Coated Balloon Angioplasty with Uncoated Balloon Angioplasty in DES Restenosis

The Pacifier Trial. A Randomized Multicenter Trial Evaluating Prevention of Restenosis with Paclitaxel-Coated PTA Balloon Catheters in Stenosis or Occlusion of Femoropopliteal...

5-year THUNDER Follow-Up: Patients with PAD Treated with Uncoated Versus Paccocath Paclitaxel Coated Balloons.

PEPCAD-DES: Drug-Coated Balloon Better Than Uncoated Balloon for DES Restenosis

Drug-Eluting Balloons an Option for Patients with BMS Restenosis, High Bleeding Risk

Paclitaxel-coated balloon angioplasty demonstrates superior results

Drug-Eluting Balloon Continues to Show Positive Results in SFA, Popliteal Disease

EuroPCR 2011: Novel Technologies with Transformative Potential Stand Out

Paclitaxel Balloon Maintains Advantage at 5 Years

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content